2023-05-01 2024-04-30 false Capium Accounts Production 1.1 14073755 2023-05-01 2024-04-30 14073755 bus:FullAccounts 2023-05-01 2024-04-30 14073755 bus:FRS102 2023-05-01 2024-04-30 14073755 bus:AuditExemptWithAccountantsReport 2023-05-01 2024-04-30 14073755 bus:SmallCompaniesRegimeForAccounts 2023-05-01 2024-04-30 14073755 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 14073755 2023-05-01 2024-04-30 14073755 2024-04-30 14073755 bus:RegisteredOffice 2023-05-01 2024-04-30 14073755 core:WithinOneYear 2024-04-30 14073755 core:AfterOneYear 2024-04-30 14073755 1 2023-05-01 2024-04-30 14073755 bus:Director1 2023-05-01 2024-04-30 14073755 bus:Director1 2024-04-30 14073755 bus:Director1 2022-04-27 2023-04-30 14073755 bus:Director2 2023-05-01 2024-04-30 14073755 bus:Director2 2024-04-30 14073755 bus:Director2 2022-04-27 2023-04-30 14073755 bus:Director3 2023-05-01 2024-04-30 14073755 bus:Director3 2024-04-30 14073755 bus:Director3 2022-04-27 2023-04-30 14073755 2022-04-27 14073755 bus:LeadAgentIfApplicable 2023-05-01 2024-04-30 14073755 2022-04-27 2023-04-30 14073755 2023-04-30 14073755 core:WithinOneYear 2023-04-30 14073755 core:AfterOneYear 2023-04-30 14073755 bus:EntityAccountantsOrAuditors 2022-04-27 2023-04-30 14073755 bus:OrdinaryShareClass1 2023-05-01 2024-04-30 14073755 bus:OrdinaryShareClass1 2024-04-30 14073755 bus:OrdinaryShareClass1 2022-04-27 2023-04-30 14073755 bus:OrdinaryShareClass1 2023-04-30 14073755 core:CostValuation core:Non-currentFinancialInstruments 2024-04-30 14073755 core:CostValuation core:Non-currentFinancialInstruments 2023-04-30 14073755 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-04-30 14073755 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-04-30 14073755 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-04-30 14073755 core:Non-currentFinancialInstruments 2024-04-30 14073755 core:Non-currentFinancialInstruments 2023-04-30 14073755 core:ShareCapital 2024-04-30 14073755 core:ShareCapital 2023-04-30 14073755 core:RetainedEarningsAccumulatedLosses 2024-04-30 14073755 core:RetainedEarningsAccumulatedLosses 2023-04-30 14073755 core:ShareCapitalOrdinaryShares 2023-05-01 14073755 core:ShareCapitalOrdinaryShares 2022-04-27 14073755 core:ShareCapitalOrdinaryShares 2023-05-01 2024-04-30 14073755 core:ShareCapitalOrdinaryShares 2022-04-27 2023-04-30 14073755 core:ShareCapitalOrdinaryShares 2024-04-30 14073755 core:ShareCapitalOrdinaryShares 2023-04-30 14073755 core:RetainedEarningsAccumulatedLosses 2023-05-01 14073755 core:RetainedEarningsAccumulatedLosses 2022-04-27 14073755 core:RetainedEarningsAccumulatedLosses 2023-05-01 2024-04-30 14073755 core:RetainedEarningsAccumulatedLosses 2022-04-27 2023-04-30 14073755 core:RetainedEarningsAccumulatedLosses 2024-04-30 14073755 core:RetainedEarningsAccumulatedLosses 2023-04-30 14073755 dpl:Item1 2023-05-01 14073755 dpl:Item1 2024-04-30 14073755 dpl:Item1 2022-04-27 14073755 dpl:Item1 2023-04-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 14073755
England and Wales

 

 

 

SILVER JOY HEALTHCARE LIMITED


Unaudited Financial Statements
 


Period of accounts

Start date: 01 May 2023

End date: 30 April 2024
Directors Amarachi Ugorji Okwara
Emeka Peter Okwara
Emeka Peter OKWARE
Registered Number 14073755
Registered Office 1 MONTROSE ROAD
CV22 5PB
Accountants SA Accountancy Practice
Equitable House
10 Woolwich New Road
London
SE186AB
1
Director's report and financial statements
The directors present his/her/their annual report and the financial statements for the year ended 30 April 2024.
Principal activities
Principal activity of the company during the financial year was of 86102 - Medical nursing home activities; 87100 - Residential nursing care facilities
Directors
The directors who served the company throughout the year were as follows:
Amarachi Ugorji Okwara
Emeka Peter Okwara
Emeka Peter OKWARE
Statement of directors' responsibilities
The directors are responsible for preparing the directors' report and the financial statements in accordance with applicable law and regulations and in accordance with United Kingdom Generally Accepted Accounting Practice.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period.
In preparing these financial statements, the directors are required to :
  • select suitable accounting policies and then apply them consistently
  • make judgements and accounting estimates that are reasonable and prudent
  • state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements and
  • prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. The directors are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The directors are responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom, governing the preparation and dissemination of financial statements, may differ from legislation in other jurisdictions

This report was approved by the board and signed on its behalf by:


----------------------------------
Amarachi Ugorji Okwara
Director

Date approved: 21 January 2025
2
Accountant’s report
You consider that the company is exempt from an audit for the year ended 30 April 2024 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
SA Accountancy Practice
30 April 2024



....................................................

SA Accountancy Practice

Equitable House
10 Woolwich New Road
London
SE186AB
21 January 2025
3
 
 
Notes
 
2024
£
  2023
£
Current assets      
Debtors 4 10,847   
Cash at bank and in hand 4,576    12,786 
15,423    12,786 
Creditors: amount falling due within one year 5 (18,200)   9,122 
Net current assets (2,777)   21,908 
 
Total assets less current liabilities (2,777)   21,908 
Net assets (2,777)   21,908 
 

Capital and reserves
     
Called up share capital 6 50    50 
Profit and loss account (2,827)   21,858 
Shareholders' funds (2,777)   21,908 
 


For the year ended 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the board of directors on 21 January 2025 and were signed on its behalf by:


-------------------------------
Amarachi Ugorji Okwara
Director
4
  Equity share capital   Retained Earnings   Total
£ £ £
Profit for the year 21,858  21,858 
Total comprehensive income for the year 21,858  21,858 
Shares issued 50  50 
Total investments by and distributions to owners 50  50 
At 30 April 2023 50  21,858  21,908 
At 01 May 2023 50  21,858  21,908 
Profit for the year 5,329  5,329 
Total comprehensive income for the year 5,329  5,329 
Dividends (30,014) (30,014)
Total investments by and distributions to owners (30,014) (30,014)
At 30 April 2024 50  (2,827) (2,777)
5
General Information
SILVER JOY HEALTHCARE LIMITED is a private company, limited by shares, registered in England and Wales, registration number 14073755, registration address 1 MONTROSE ROAD, CV22 5PB.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Going concern basis
The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Dividends
Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.
2.

Staff Costs

2024
£
  2023
£
Wages and salaries 12,000    12,500 
Other staff costs 2,191   
14,191    12,500 
 
Average number of employees during the year Number   Number
Administration 2   
 

3.

Average number of employees

Average number of employees during the year was 2 (2023 : 0).
4.

Debtors: amounts falling due within one year

2024
£
  2023
£
Other Debtors 1,725   
1,725   

4.

Debtors: amounts falling due after one year

2024
£
  2023
£
Other Debtors 9,122   
9,122   

5.

Creditors: amount falling due within one year

2024
£
  2023
£
Trade Creditors 1,200   
Dividends Payable - Equity   (9,122)
Directors' Current Accounts 17,000   
18,200    (9,122)

6.

Share Capital

Authorised
50 Class A shares of £1.00 each
Allotted, called up and fully paid
2024
£
  2023
£
0 Class A share of £1.00 each  
 

6